Your browser doesn't support javascript.
loading
Using CD19 chimeric antigen receptor-T cell therapy in a 4-month-old patient with infantile acute lymphoblastic leukemia.
Shyr, David C; Homsombath, Amy A; Chan, Priya P; Boyer, Michael W; Harris, Andrew C.
Afiliación
  • Shyr DC; Division of Pediatric Hematology/Oncology, University of Utah School of Medicine, Salt Lake City, Utah.
  • Homsombath AA; Cell Therapy & Regenerative Medicine Program, University of Utah School of Medicine, Salt Lake City, Utah.
  • Chan PP; Division of Pediatric Hematology/Oncology, University of Utah School of Medicine, Salt Lake City, Utah.
  • Boyer MW; Division of Pediatric Hematology/Oncology, University of Utah School of Medicine, Salt Lake City, Utah.
  • Harris AC; Division of Pediatric Hematology/Oncology, University of Utah School of Medicine, Salt Lake City, Utah.
Pediatr Blood Cancer ; 67(4): e28155, 2020 04.
Article en En | MEDLINE | ID: mdl-31925900

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Antígenos CD19 / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Prognostic_studies Límite: Female / Humans / Infant Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Antígenos CD19 / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Prognostic_studies Límite: Female / Humans / Infant Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2020 Tipo del documento: Article